the aid library

LIST OPTIONS

Filter

2243

Sort by:

Direction:

Download (3002)

View PDF (868)

Philippines: HIV Immunization Guidelines

Rontgene M. Solante, Manolito L. Chua Philippine Society for Microbiology and Infectious Diseases (2010) C1

Download (376)

View PDF (897)

Save One Million Lives Program for Results

Nigeria, Federal Ministry of Health (2016) C1

Program Implementation Manual (PIM)
The Save One Million Lives Program for Results (SOML PforR) is a Federal Government of Nigeria maternal and child health program, supported by the World Bank, which provides incentives based on achievement of results (health outcomes) and helps to drive insti... more

Download (842)

View PDF (1388)

National Training Package on Paediatric HIV and AIDS Care and Treatment. Participants Handbook: Module 1: Overview of HIV in Children

Ministry of Health and Social Welfare, Tanzania (2015) C1

Download (1047)

View PDF (2968)

Manual on paediatric HIV care and treatment for district hospitals

World Health Organization WHO (2011) C_WHO

Download (823)

View PDF (1600)

Introduction to the Core Curriculum on Tuberculosis: What the Clinician Should Know

Center for Disease Control and Prevention (2013)

Sixth Edition

Download (1224)

View PDF (1607)

Evaluation guidelines for Measles supplemental immunization activities

World Health Organization; Regional Office for Africa (2006)

Download (341)

View PDF (292)

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19
recommended

World Health Organization WHO (2021) C_WHO

Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident... more

Download (152)

View PDF (124)

Clinical Handbook on the health care of Survivors Subjected to Intimate Partner Violence and/or Sexual Violence, Namibia

Ministry of Health and Social Services, Namibia; WHO; UNFPA; et al. (2020) C_WHO

This handbook is an adaptation from the WHO Clinical Handbook Health care for women subjected to intimate partner violence or sexual violence developed by the World Health Organization (WHO), UN Women and United Nations Population Fund. The handbook draws on the work from professionals who are dedic... more

Download (125)

View PDF (128)

COVID-19 Vaccine Operational Guidelines

Ministry of Health and Family Welfare, Government of India (2020) C1

Updated 28 December 2020

Download (59)

View PDF (87)

National Guidance on Tetanus Prevention in Voluntary Medical Male Circumcision Settings in Kenya

Ministry of Health, Kenya (2018) CC

Download (110)

View PDF (140)

COVID-19: Strategic preparedness and response plan for WHO African Region 1 February 2021-31 January 2022 (Update of 16 April 2021)

World Health Organization WHO, Regional Office of Africa; UNICEF (2021) C_WHO

The 2021 COVID-19 Strategic Preparedness and Response Plan (SPRP) for AFR serves as a regional guide for a holistic public health response to COVID‑19 at regional, national and sub-national levels. The 2021 SPRP: 1. Builds upon the lessons learnt from the implementation of the 2020 SPRP and outl... more

Download (167)

View PDF (219)

Guidelines for developing a national immunization strategy: frequently asked questions, key concepts and terms

World Health Organization WHO (2021) C_WHO

Download (137)

View PDF (173)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Download (117)

View PDF (95)

Risk management Plan Guideline for COVID-19 Vaccines

Ethiopian Food and Drug Authority (2021) CC

July 2021

Download (92)

View PDF (132)

WHO COVID-19 policy brief: building trust through risk communication and community engagement, 14 September 2022

World Health Organization WHO (2022) C_WHO

The guidance notes describe key actions that policy-makers at national and subnational levels can take in relation to: diagnostic testing for COVID-19, clinical management of COVID-19, meeting targets for vaccination against COVID-19, maintaining infection control measures for COVID-19 in health-car... more

Download (148)

View PDF (187)

Control measures for Shiga toxin-producing Escherichia coli (‎STEC)‎ associated with meat and dairy products: meeting report

World Health Organisation (WHO) (2022) C_WHO

Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the... more

Download (154)

View PDF (191)

Mpox Strategic Preparedness, Readiness, and Response Plan: Global Monitoring and Evaluation Framework

World Health Organization WHO Reliefweb OCHA Services (2022) C_WHO

This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da... more

Download (163)

View PDF (144)

Nigeria: reducing the indirect causes of maternal morbidity and mortality: the RICOM3 Project

World Health Organisation (WHO) (2023) C_WHO

Nigeria reported its first case of COVID-19 at the end of February 2020 and subsequently experienced four waves, with peaks in June 2020 and January, August and December 2021. The COVID-19 pandemic severely impacted the economy of Nigeria and caused disruption of health services nationwide. During... more

Download (106)

View PDF (116)

Building better immunity: A life course approach to healthy longevity

Pan American Health Organization PAHO (2023) C_WHO

As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt... more

Download (93)

View PDF (89)

Guidance on the use of mpox vaccines. Revised edition

Pan American Health Organisation PAHO (2024) CC

Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr... more

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19 recommended

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19
recommended